We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

New ‘Double Decker’ Antibody-drug Conjugates Fight Cancer

News   Oct 30, 2017 | Original story from The Scripps Research Institute (TSRI)

 
New ‘Double Decker’ Antibody-drug Conjugates Fight Cancer

Left to right: This is an image of study leaders TSRI Professor William R. Roush, Graduate Student Alex Nanna and TSRI Associate Professor Christoph Rader. Credit: The Scripps Research Institute

 
 
Advertisement
 

RELATED ARTICLES

Amarna Therapeutics Appoints Kite Pharma Veteran Dr. Markwin Velders to its Supervisory Board

News

Amarna Therapeutics today announced the appointment of former VP Operations and Managing Director at Kite Pharma EU, Dr. Markwin Velders to its Supervisory Board.

READ MORE

Common Diabetes Drugs May Help Prevent Parkinson’s Disease, Large Study Finds

News

Elevated risk of Parkinson’s disease among people with type 2 diabetes appears to be reduced by some medications used to treat their diabetes, finds a new study led by UCL researchers.

READ MORE

Alterations in Subcellular Traffic Increases Invasiveness of Radioresistant Cancer Cells

News

Scientists have revealed the molecular mechanism regulating the trafficking of lysosomes that increases the invasiveness of radioresistant cancer cells following radiotherapy.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Cancer Research Cell Science Diagnostics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE